<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32575372</PMID><DateCompleted><Year>2021</Year><Month>03</Month><Day>18</Day></DateCompleted><DateRevised><Year>2022</Year><Month>05</Month><Day>18</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2073-4425</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>6</Issue><PubDate><Year>2020</Year><Month>Jun</Month><Day>19</Day></PubDate></JournalIssue><Title>Genes</Title><ISOAbbreviation>Genes (Basel)</ISOAbbreviation></Journal><ArticleTitle>A Knowledge-Based Machine Learning Approach to Gene Prioritisation in Amyotrophic Lateral Sclerosis.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">668</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/genes11060668</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis is a neurodegenerative disease of the upper and lower motor neurons resulting in death from neuromuscular respiratory failure, typically within two to five years of first symptoms. Several rare disruptive gene variants have been associated with ALS and are responsible for about 15% of all cases. Although our knowledge of the genetic landscape of this disease is improving, it remains limited. Machine learning models trained on the available protein-protein interaction and phenotype-genotype association data can use our current knowledge of the disease genetics for the prediction of novel candidate genes. Here, we describe a knowledge-based machine learning method for this purpose. We trained our model on protein-protein interaction data from IntAct, gene function annotation from Gene Ontology, and known disease-gene associations from DisGeNet. Using several sets of known ALS genes from public databases and a manual review as input, we generated a list of new candidate genes for each input set. We investigated the relevance of the predicted genes in ALS by using the available summary statistics from the largest ALS genome-wide association study and by performing functional and phenotype enrichment analysis. The predicted sets were enriched for genes associated with other neurodegenerative diseases known to overlap with ALS genetically and phenotypically, as well as for biological processes associated with the disease. Moreover, using ALS genes from ClinVar and our manual review as input, the predicted sets were enriched for ALS-associated genes (ClinVar <i>p</i> = 0.038 and manual review <i>p</i> = 0.060) when used for gene prioritisation in a genome-wide association study.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bean</LastName><ForeName>Daniel M</ForeName><Initials>DM</Initials><AffiliationInfo><Affiliation>Department of Biostatistics &amp; Health Informatics, King's College London, 16 De Crespigny Park, London SE5 8AF, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Health Data Research UK London, University College London, 16 De Crespigny Park, London SE5 8AF, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Chalabi</LastName><ForeName>Ammar</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-4924-7712</Identifier><AffiliationInfo><Affiliation>King's College Hospital, Bessemer Road, Denmark Hill, Brixton, London SE5 9RS, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Maurice Wohl Clinical Neuroscience Institute, Department of Basic and Clinical Neuroscience, King's College London, London, 5 Cutcombe Rd, Brixton, London SE5 9RT, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dobson</LastName><ForeName>Richard J B</ForeName><Initials>RJB</Initials><AffiliationInfo><Affiliation>Department of Biostatistics &amp; Health Informatics, King's College London, 16 De Crespigny Park, London SE5 8AF, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Health Data Research UK London, University College London, 16 De Crespigny Park, London SE5 8AF, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Health Informatics, University College London, 222 Euston Rd, London NW1 2DA, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Iacoangeli</LastName><ForeName>Alfredo</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-5280-5017</Identifier><AffiliationInfo><Affiliation>Department of Biostatistics &amp; Health Informatics, King's College London, 16 De Crespigny Park, London SE5 8AF, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Maurice Wohl Clinical Neuroscience Institute, Department of Basic and Clinical Neuroscience, King's College London, London, 5 Cutcombe Rd, Brixton, London SE5 9RT, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>AL-CHALABI/APR15/844-791</GrantID><Acronym>MNDA_</Acronym><Agency>Motor Neurone Disease Association</Agency><Country>United Kingdom</Country></Grant><Grant><Acronym>BHF_</Acronym><Agency>British Heart Foundation</Agency><Country>United Kingdom</Country></Grant><Grant><Acronym>DH_</Acronym><Agency>Department of Health</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MC_PC_17214</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MR/R024804/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MR/S00310X/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>ALCHALABI-DOBSON/APR14/829-791</GrantID><Acronym>MNDA_</Acronym><Agency>Motor Neurone Disease Association</Agency><Country>United Kingdom</Country></Grant><Grant><Acronym>CSO_</Acronym><Agency>Chief Scientist Office</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MR/L501529/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MR/L501529/1 and MR/R024804/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>171</GrantID><Acronym>ALZS_</Acronym><Agency>Alzheimer's Society</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>06</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Genes (Basel)</MedlineTA><NlmUniqueID>101551097</NlmUniqueID><ISSNLinking>2073-4425</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D056726" MajorTopicYN="N">Genetic Association Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="N">Genetic Predisposition to Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055106" MajorTopicYN="N">Genome-Wide Association Study</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005838" MajorTopicYN="N">Genotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051188" MajorTopicYN="Y">Knowledge Bases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="Y">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="N">Neurodegenerative Diseases</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">gene discovery</Keyword><Keyword MajorTopicYN="N">gene prioritisation</Keyword><Keyword MajorTopicYN="N">knowledge graph</Keyword><Keyword MajorTopicYN="N">machine learning</Keyword><Keyword MajorTopicYN="N">motor neurone disease</Keyword></KeywordList><CoiStatement>The other authors declare no competing interests</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>5</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>6</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>6</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>6</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>6</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>3</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32575372</ArticleId><ArticleId IdType="pmc">PMC7349022</ArticleId><ArticleId IdType="doi">10.3390/genes11060668</ArticleId><ArticleId IdType="pii">genes11060668</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Brown R.H., Al-Chalabi A. Amyotrophic lateral sclerosis. N. Engl. J. Med. 2017;377:162&#x2013;172. doi: 10.1056/NEJMra1603471.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1603471</ArticleId><ArticleId IdType="pubmed">28700839</ArticleId></ArticleIdList></Reference><Reference><Citation>Abel O., Powell J.F., Andersen P.M., Al-Chalabi A. ALSoD: A user-friendly online bioinformatics tool for amyotrophic lateral sclerosis genetics. Hum. Mutat. 2012;33:1345&#x2013;1351. doi: 10.1002/humu.22157.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/humu.22157</ArticleId><ArticleId IdType="pubmed">22753137</ArticleId></ArticleIdList></Reference><Reference><Citation>Iacoangeli A., Al Khleifat A., Sproviero W., Shatunov A., Jones A.R., Opie-Martin S., Naselli E., Topp S.D., Fogh I., Hodges A., et al. ALSgeneScanner: A pipeline for the analysis and interpretation of DNA sequencing data of ALS patients. Amyotroph. Lateral Scler. Front. Degener. 2019;20:207&#x2013;215. doi: 10.1080/21678421.2018.1562553.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2018.1562553</ArticleId><ArticleId IdType="pmc">PMC6567555</ArticleId><ArticleId IdType="pubmed">30835568</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton A.E., Chi&#xf2; A., Traynor B.J. State of play in amyotrophic lateral sclerosis genetics. Nat. Neurosci. 2014;17:17&#x2013;23. doi: 10.1038/nn.3584.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3584</ArticleId><ArticleId IdType="pmc">PMC4544832</ArticleId><ArticleId IdType="pubmed">24369373</ArticleId></ArticleIdList></Reference><Reference><Citation>Chia R., Chi&#xf2; A., Traynor B.J. Novel genes associated with amyotrophic lateral sclerosis: Diagnostic and clinical implications. Lancet Neurol. 2018;17:94&#x2013;102. doi: 10.1016/S1474-4422(17)30401-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(17)30401-5</ArticleId><ArticleId IdType="pmc">PMC5901717</ArticleId><ArticleId IdType="pubmed">29154141</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Chalabi A. Perspective: Don&#x2019;t keep it in the family. Nature. 2017;550:S112. doi: 10.1038/550S112a.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/550S112a</ArticleId><ArticleId IdType="pubmed">29045374</ArticleId></ArticleIdList></Reference><Reference><Citation>Stelzl U., Wanker E.E. The value of high quality protein&#x2013;protein interaction networks for systems biology. Curr. Opin. Chem. Biol. 2006;10:551&#x2013;558. doi: 10.1016/j.cbpa.2006.10.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cbpa.2006.10.005</ArticleId><ArticleId IdType="pubmed">17055769</ArticleId></ArticleIdList></Reference><Reference><Citation>Pi&#xf1;ero J., Bravo &#xc0;., Queralt-Rosinach N., Guti&#xe9;rrez-Sacrist&#xe1;n A., Deu-Pons J., Centeno E., Garc&#xed;a-Garc&#xed;a J., Sanz F., Furlong L.I. DisGeNET: A comprehensive platform integrating information on human disease-associated genes and variants. Nucleic Acids Res. 2016;45:D833&#x2013;D839. doi: 10.1093/nar/gkw943.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkw943</ArticleId><ArticleId IdType="pmc">PMC5210640</ArticleId><ArticleId IdType="pubmed">27924018</ArticleId></ArticleIdList></Reference><Reference><Citation>Iacoangeli A., Al Khleifat A., Sproviero W., Shatunov A., Jones A., Morgan S., Pittman A., Dobson R., Newhouse S., Al-Chalabi A. DNAscan: Personal computer compatible NGS analysis, annotation and visualisation. BMC Bioinform. 2019;20:213. doi: 10.1186/s12859-019-2791-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12859-019-2791-8</ArticleId><ArticleId IdType="pmc">PMC6487045</ArticleId><ArticleId IdType="pubmed">31029080</ArticleId></ArticleIdList></Reference><Reference><Citation>Gandhi T., Zhong J., Mathivanan S., Karthick L., Chandrika K., Mohan S.S., Sharma S., Pinkert S., Nagaraju S., Periaswamy B., et al. Analysis of the human protein interactome and comparison with yeast, worm and fly interaction datasets. Nat. Genet. 2006;38:285&#x2013;293. doi: 10.1038/ng1747.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng1747</ArticleId><ArticleId IdType="pubmed">16501559</ArticleId></ArticleIdList></Reference><Reference><Citation>Oti M., Brunner H.G. The modular nature of genetic diseases. Clin. Genet. 2007;71:1&#x2013;11. doi: 10.1111/j.1399-0004.2006.00708.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1399-0004.2006.00708.x</ArticleId><ArticleId IdType="pubmed">17204041</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin C.-H., Konecki D.M., Liu M., Wilson S.J., Nassar H., Wilkins A.D., Gleich D.F., Lichtarge O. Multimodal network diffusion predicts future disease&#x2013;gene&#x2013;chemical associations. Bioinformatics. 2019;35:1536&#x2013;1543. doi: 10.1093/bioinformatics/bty858.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/bty858</ArticleId><ArticleId IdType="pmc">PMC6499233</ArticleId><ArticleId IdType="pubmed">30304494</ArticleId></ArticleIdList></Reference><Reference><Citation>K&#xf6;hler S., Bauer S., Horn D., Robinson P.N. Walking the interactome for prioritization of candidate disease genes. Am. J. Hum. Genet. 2008;82:949&#x2013;958. doi: 10.1016/j.ajhg.2008.02.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajhg.2008.02.013</ArticleId><ArticleId IdType="pmc">PMC2427257</ArticleId><ArticleId IdType="pubmed">18371930</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng J., Bai K., Shang X., Wang G., Xue H., Jin S., Cheng L., Wang Y., Chen J. Predicting disease-related genes using integrated biomedical networks. BMC Genom. 2017;18:1043. doi: 10.1186/s12864-016-3263-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12864-016-3263-4</ArticleId><ArticleId IdType="pmc">PMC5310285</ArticleId><ArticleId IdType="pubmed">28198675</ArticleId></ArticleIdList></Reference><Reference><Citation>Vanunu O., Magger O., Ruppin E., Shlomi T., Sharan R. Associating genes and protein complexes with disease via network propagation. PLoS Comput. Biol. 2010;6:e1000641. doi: 10.1371/journal.pcbi.1000641.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pcbi.1000641</ArticleId><ArticleId IdType="pmc">PMC2797085</ArticleId><ArticleId IdType="pubmed">20090828</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou H., Skolnick J. A knowledge-based approach for predicting gene&#x2013;disease associations. Bioinformatics. 2016;32:2831&#x2013;2838. doi: 10.1093/bioinformatics/btw358.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btw358</ArticleId><ArticleId IdType="pmc">PMC5018378</ArticleId><ArticleId IdType="pubmed">27283949</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng X., Liao Y., Liu Y., Zou Q. Prediction and validation of disease genes using HeteSim Scores. IEEE/ACM Trans. Comput. Biol. Bioinform. 2016;14:687&#x2013;695. doi: 10.1109/TCBB.2016.2520947.</Citation><ArticleIdList><ArticleId IdType="doi">10.1109/TCBB.2016.2520947</ArticleId><ArticleId IdType="pubmed">26890920</ArticleId></ArticleIdList></Reference><Reference><Citation>Ata S.K., Ou-Yang L., Fang Y., Kwoh C.-K., Wu M., Li X.-L. Integrating node embeddings and biological annotations for genes to predict disease-gene associations. BMC Syst. Biol. 2018;12:138. doi: 10.1186/s12918-018-0662-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12918-018-0662-y</ArticleId><ArticleId IdType="pmc">PMC6311944</ArticleId><ArticleId IdType="pubmed">30598097</ArticleId></ArticleIdList></Reference><Reference><Citation>Grover A., Leskovec J. node2vec: Scalable feature learning for networks; Proceedings of the 22nd ACM SIGKDD International Conference on Knowledge Discovery and Data Mining; San Francisco, CA, USA. 13&#x2013;17 August 2016; New York, NY, USA: ACM; 2016. pp. 855&#x2013;864.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5108654</ArticleId><ArticleId IdType="pubmed">27853626</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu X., Jiang R., Zhang M.Q., Li S. Network-based global inference of human disease genes. Mol. Syst. Biol. 2008:4. doi: 10.1038/msb.2008.27.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/msb.2008.27</ArticleId><ArticleId IdType="pmc">PMC2424293</ArticleId><ArticleId IdType="pubmed">18463613</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin L., Yang T., Fang L., Yang J., Yang F., Zhao J. Gene gravity-like algorithm for disease gene prediction based on phenotype-specific network. BMC Syst. Biol. 2017;11:121. doi: 10.1186/s12918-017-0519-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12918-017-0519-9</ArticleId><ArticleId IdType="pmc">PMC5718078</ArticleId><ArticleId IdType="pubmed">29212543</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo P., Li Y., Tian L.-P., Wu F.-X. Enhancing the prediction of disease&#x2013;gene associations with multimodal deep learning. Bioinformatics. 2019;35:3735&#x2013;3742. doi: 10.1093/bioinformatics/btz155.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btz155</ArticleId><ArticleId IdType="pubmed">30825303</ArticleId></ArticleIdList></Reference><Reference><Citation>Asif M., Martiniano H.F., Vicente A.M., Couto F.M. Identifying disease genes using machine learning and gene functional similarities, assessed through Gene Ontology. PLoS ONE. 2018;13:e0208626. doi: 10.1371/journal.pone.0208626.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0208626</ArticleId><ArticleId IdType="pmc">PMC6287949</ArticleId><ArticleId IdType="pubmed">30532199</ArticleId></ArticleIdList></Reference><Reference><Citation>Bean D.M., Wu H., Iqbal E., Dzahini O., Ibrahim Z.M., Broadbent M., Stewart R., Dobson R.J. Knowledge graph prediction of unknown adverse drug reactions and validation in electronic health records. Sci. Rep. 2017;7:16416. doi: 10.1038/s41598-017-16674-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-16674-x</ArticleId><ArticleId IdType="pmc">PMC5703951</ArticleId><ArticleId IdType="pubmed">29180758</ArticleId></ArticleIdList></Reference><Reference><Citation>Orchard S., Ammari M., Aranda B., Breuza L., Briganti L., Broackes-Carter F., Campbell N.H., Chavali G., Chen C., Del-Toro N., et al. The MIntAct project&#x2014;IntAct as a common curation platform for 11 molecular interaction databases. Nucleic Acids Res. 2014;42:D358&#x2013;D363. doi: 10.1093/nar/gkt1115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkt1115</ArticleId><ArticleId IdType="pmc">PMC3965093</ArticleId><ArticleId IdType="pubmed">24234451</ArticleId></ArticleIdList></Reference><Reference><Citation>The Gene Ontology Consortium. Dolinski K., Dwight S.S., Eppig J.T., Harris M.A., Hill D.P., Issel-Tarver L., Kasarskis A., Lewis S., Matese J., et al. Gene ontology: Tool for the unification of biology. Nat. Genet. 2000;25:25&#x2013;29.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3037419</ArticleId><ArticleId IdType="pubmed">10802651</ArticleId></ArticleIdList></Reference><Reference><Citation>Acencio M.L., L&#xe6;greid A., Kuiper M. The Gene Ontology Resource: 20 Years and Still Going Strong. Nucleic Acids Res. 2019;47:D330&#x2013;D338. doi: 10.1093/nar/gky1055.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gky1055</ArticleId><ArticleId IdType="pmc">PMC6323945</ArticleId><ArticleId IdType="pubmed">30395331</ArticleId></ArticleIdList></Reference><Reference><Citation>Pi&#xf1;ero J., Ram&#xed;rez-Anguita J.M., Sa&#xfc;ch-Pitarch J., Ronzano F., Centeno E., Sanz F., Furlong L.I. The DisGeNET knowledge platform for disease genomics: 2019 Update. Nucleic Acids Res. 2020;48:D845&#x2013;D855. doi: 10.1093/nar/gkz1021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkz1021</ArticleId><ArticleId IdType="pmc">PMC7145631</ArticleId><ArticleId IdType="pubmed">31680165</ArticleId></ArticleIdList></Reference><Reference><Citation>Wroe R., Wai-Ling Butler A., Andersen P.M., Powell J.F., Al-Chalabi A. ALSOD: The Amyotrophic Lateral Sclerosis Online Database. Amyotroph. Lateral Scler. 2008;9:249&#x2013;250. doi: 10.1080/17482960802146106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17482960802146106</ArticleId><ArticleId IdType="pubmed">18608099</ArticleId></ArticleIdList></Reference><Reference><Citation>Landrum M.J., Lee J.M., Riley G.R., Jang W., Rubinstein W.S., Church D.M., Maglott D.R. ClinVar: Public archive of relationships among sequence variation and human phenotype. Nucleic Acids Res. 2014;42:D980&#x2013;D985. doi: 10.1093/nar/gkt1113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkt1113</ArticleId><ArticleId IdType="pmc">PMC3965032</ArticleId><ArticleId IdType="pubmed">24234437</ArticleId></ArticleIdList></Reference><Reference><Citation>Mi H., Muruganujan A., Ebert D., Huang X., Thomas P.D. PANTHER version 14: More genomes, a new PANTHER GO-slim and improvements in enrichment analysis tools. Nucleic Acids Res. 2019;47:D419&#x2013;D426. doi: 10.1093/nar/gky1038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gky1038</ArticleId><ArticleId IdType="pmc">PMC6323939</ArticleId><ArticleId IdType="pubmed">30407594</ArticleId></ArticleIdList></Reference><Reference><Citation>Supek F., Bo&#x161;njak M., &#x160;kunca N., &#x160;muc T. REVIGO summarizes and visualizes long lists of gene ontology terms. PLoS ONE. 2011;6:e21800. doi: 10.1371/journal.pone.0021800.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0021800</ArticleId><ArticleId IdType="pmc">PMC3138752</ArticleId><ArticleId IdType="pubmed">21789182</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuleshov M.V., Jones M.R., Rouillard A.D., Fernandez N.F., Duan Q., Wang Z., Koplev S., Jenkins S.L., Jagodnik K.M., Lachmann A., et al. Enrichr: A comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Res. 2016;44:W90&#x2013;W97. doi: 10.1093/nar/gkw377.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkw377</ArticleId><ArticleId IdType="pmc">PMC4987924</ArticleId><ArticleId IdType="pubmed">27141961</ArticleId></ArticleIdList></Reference><Reference><Citation>Amberger J.S., Bocchini C.A., Scott A.F., Hamosh A. Omim. org: Leveraging knowledge across phenotype&#x2013;gene relationships. Nucleic Acids Res. 2019;47:D1038&#x2013;D1043. doi: 10.1093/nar/gky1151.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gky1151</ArticleId><ArticleId IdType="pmc">PMC6323937</ArticleId><ArticleId IdType="pubmed">30445645</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamosh A., Scott A.F., Amberger J.S., Bocchini C.A., McKusick V.A. Online Mendelian Inheritance in Man (OMIM), a knowledgebase of human genes and genetic disorders. Nucleic Acids Res. 2005;33:D514&#x2013;D517. doi: 10.1093/nar/gki033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gki033</ArticleId><ArticleId IdType="pmc">PMC539987</ArticleId><ArticleId IdType="pubmed">15608251</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicolas A., Kenna K.P., Renton A.E., Ticozzi N., Faghri F., Chia R., Dominov J.A., Kenna B.J., Nalls M.A., Keagle P., et al. Genome-wide analyses identify KIF5A as a novel ALS gene. Neuron. 2018;97:1268&#x2013;1283. doi: 10.1016/j.neuron.2018.02.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2018.02.027</ArticleId><ArticleId IdType="pmc">PMC5867896</ArticleId><ArticleId IdType="pubmed">29566793</ArticleId></ArticleIdList></Reference><Reference><Citation>Pe&#x2019;er I., Yelensky R., Altshuler D., Daly M.J. Estimation of the multiple testing burden for genomewide association studies of nearly all common variants. Genet. Epidemiol. Off. Publ. Int. Genet. Epidemiol. Soc. 2008;32:381&#x2013;385. doi: 10.1002/gepi.20303.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/gepi.20303</ArticleId><ArticleId IdType="pubmed">18348202</ArticleId></ArticleIdList></Reference><Reference><Citation>The 1000 Genomes Project Consortium A global reference for human genetic variation. Nature. 2015;526:68&#x2013;74. doi: 10.1038/nature15393.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature15393</ArticleId><ArticleId IdType="pmc">PMC4750478</ArticleId><ArticleId IdType="pubmed">26432245</ArticleId></ArticleIdList></Reference><Reference><Citation>de Leeuw C.A., Mooij J.M., Heskes T., Posthuma D. MAGMA: Generalized gene-set analysis of GWAS data. PLoS Comput. Biol. 2015;11:e1004219. doi: 10.1371/journal.pcbi.1004219.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pcbi.1004219</ArticleId><ArticleId IdType="pmc">PMC4401657</ArticleId><ArticleId IdType="pubmed">25885710</ArticleId></ArticleIdList></Reference><Reference><Citation>Oosthuyse B., Moons L., Storkebaum E., Beck H., Nuyens D., Brusselmans K., Van Dorpe J., Hellings P., Gorselink M., Heymans S., et al. Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration. Nat. Genet. 2001;28:131&#x2013;138. doi: 10.1038/88842.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/88842</ArticleId><ArticleId IdType="pubmed">11381259</ArticleId></ArticleIdList></Reference><Reference><Citation>Adibhatla R.M., Hatcher J.F. Role of lipids in brain injury and diseases. Future Lipidol. 2007;2:403&#x2013;422. doi: 10.2217/17460875.2.4.403.</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/17460875.2.4.403</ArticleId><ArticleId IdType="pmc">PMC2174836</ArticleId><ArticleId IdType="pubmed">18176634</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith E.F., Shaw P.J., De Vos K.J. The role of mitochondria in amyotrophic lateral sclerosis. Neurosci. Lett. 2019;710:132933. doi: 10.1016/j.neulet.2017.06.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2017.06.052</ArticleId><ArticleId IdType="pubmed">28669745</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo W., Vandoorne T., Steyaert J., Staats K.A., Van Den Bosch L. The multifaceted role of kinases in amyotrophic lateral sclerosis: Genetic, pathological and therapeutic implications. Brain. 2020 doi: 10.1093/brain/awaa022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awaa022</ArticleId><ArticleId IdType="pmc">PMC7296858</ArticleId><ArticleId IdType="pubmed">32206784</ArticleId></ArticleIdList></Reference><Reference><Citation>Barber S.C., Shaw P.J. Oxidative stress in ALS: Key role in motor neuron injury and therapeutic target. Free Radic. Biol. Med. 2010;48:629&#x2013;641. doi: 10.1016/j.freeradbiomed.2009.11.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2009.11.018</ArticleId><ArticleId IdType="pubmed">19969067</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowling A.C., Schulz J.B., Brown R.H., Jr., Beal M.F. Superoxide dismutase activity, oxidative damage, and mitochondrial energy metabolism in familial and sporadic amyotrophic lateral sclerosis. J. Neurochem. 1993;61:2322&#x2013;2325. doi: 10.1111/j.1471-4159.1993.tb07478.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.1993.tb07478.x</ArticleId><ArticleId IdType="pubmed">8245985</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishimura A.L., Mitne-Neto M., Silva H.C., Richieri-Costa A., Middleton S., Cascio D., Kok F., Oliveira J.R., Gillingwater T., Webb J., et al. A mutation in the vesicle-trafficking protein VAPB causes late-onset spinal muscular atrophy and amyotrophic lateral sclerosis. Am. J. Hum. Genet. 2004;75:822&#x2013;831. doi: 10.1086/425287.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/425287</ArticleId><ArticleId IdType="pmc">PMC1182111</ArticleId><ArticleId IdType="pubmed">15372378</ArticleId></ArticleIdList></Reference><Reference><Citation>Foerster B.R., Pomper M.G., Callaghan B.C., Petrou M., Edden R.A., Mohamed M.A., Welsh R.C., Carlos R.C., Barker P.B., Feldman E.L. An imbalance between excitatory and inhibitory neurotransmitters in amyotrophic lateral sclerosis revealed by use of 3-T proton magnetic resonance spectroscopy. JAMA Neurol. 2013;70:1009&#x2013;1016. doi: 10.1001/jamaneurol.2013.234.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2013.234</ArticleId><ArticleId IdType="pmc">PMC4382938</ArticleId><ArticleId IdType="pubmed">23797905</ArticleId></ArticleIdList></Reference><Reference><Citation>Lillo P., Mioshi E., Zoing M.C., Kiernan M.C., Hodges J.R. How common are behavioural changes in amyotrophic lateral sclerosis? Amyotroph. Lateral Scler. 2011;12:45&#x2013;51. doi: 10.3109/17482968.2010.520718.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482968.2010.520718</ArticleId><ArticleId IdType="pubmed">20849323</ArticleId></ArticleIdList></Reference><Reference><Citation>DeJesus-Hernandez M., Mackenzie I.R., Boeve B.F., Boxer A.L., Baker M., Rutherford N.J., Nicholson A.M., Finch N.A., Flynn H., Adamson J., et al. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron. 2011;72:245&#x2013;256. doi: 10.1016/j.neuron.2011.09.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.09.011</ArticleId><ArticleId IdType="pmc">PMC3202986</ArticleId><ArticleId IdType="pubmed">21944778</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton A.E., Majounie E., Waite A., Sim&#xf3;n-S&#xe1;nchez J., Rollinson S., Gibbs J.R., Schymick J.C., Laaksovirta H., Van Swieten J.C., Myllykangas L. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron. 2011;72:257&#x2013;268. doi: 10.1016/j.neuron.2011.09.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.09.010</ArticleId><ArticleId IdType="pmc">PMC3200438</ArticleId><ArticleId IdType="pubmed">21944779</ArticleId></ArticleIdList></Reference><Reference><Citation>McLaughlin R.L., Schijven D., Van Rheenen W., Van Eijk K.R., O&#x2019;Brien M., Kahn R.S., Ophoff R.A., Goris A., Bradley D.G., Al-Chalabi A. Genetic correlation between amyotrophic lateral sclerosis and schizophrenia. Nat. Commun. 2017;8:14770. doi: 10.1038/ncomms14774.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms14774</ArticleId><ArticleId IdType="pmc">PMC5364411</ArticleId><ArticleId IdType="pubmed">28322246</ArticleId></ArticleIdList></Reference><Reference><Citation>Trist B.G., Davies K.M., Cottam V., Genoud S., Ortega R., Roudeau S., Carmona A., De Silva K., Wasinger V., Lewis S.J., et al. Amyotrophic lateral sclerosis-like superoxide dismutase 1 proteinopathy is associated with neuronal loss in Parkinson&#x2019;s disease brain. Acta Neuropathol. 2017;134:113&#x2013;127. doi: 10.1007/s00401-017-1726-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-017-1726-6</ArticleId><ArticleId IdType="pubmed">28527045</ArticleId></ArticleIdList></Reference><Reference><Citation>Muraoka Y., Nakamura A., Tanaka R., Suda K., Azuma Y., Kushimura Y., Piccolo L.L., Yoshida H., Mizuta I., Tokuda T., et al. Genetic screening of the genes interacting with Drosophila FIG4 identified a novel link between CMT-causing gene and long noncoding RNAs. Exp. Neurol. 2018;310:1&#x2013;13. doi: 10.1016/j.expneurol.2018.08.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2018.08.009</ArticleId><ArticleId IdType="pubmed">30165075</ArticleId></ArticleIdList></Reference><Reference><Citation>Montecchiani C., Pedace L., Lo Giudice T., Casella A., Mearini M., Gaudiello F., Pedroso J.L., Terracciano C., Caltagirone C., Massa R., et al. ALS5/SPG11/KIAA1840 mutations cause autosomal recessive axonal Charcot&#x2013;Marie&#x2013;Tooth disease. Brain. 2016;139:73&#x2013;85. doi: 10.1093/brain/awv320.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awv320</ArticleId><ArticleId IdType="pmc">PMC5839554</ArticleId><ArticleId IdType="pubmed">26556829</ArticleId></ArticleIdList></Reference><Reference><Citation>Orlacchio A., Babalini C., Borreca A., Patrono C., Massa R., Basaran S., Munhoz R.P., Rogaeva E.A., St George-Hyslop P.H., Bernardi G., et al. SPATACSIN mutations cause autosomal recessive juvenile amyotrophic lateral sclerosis. Brain. 2010;133:591&#x2013;598. doi: 10.1093/brain/awp325.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awp325</ArticleId><ArticleId IdType="pmc">PMC2822627</ArticleId><ArticleId IdType="pubmed">20110243</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng P., Wang T., Zheng J., Zhou X. Causal association of type 2 diabetes with amyotrophic lateral sclerosis: New evidence from Mendelian randomization using GWAS summary statistics. BMC Med. 2019;17:225. doi: 10.1186/s12916-019-1448-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-019-1448-9</ArticleId><ArticleId IdType="pmc">PMC6892209</ArticleId><ArticleId IdType="pubmed">31796040</ArticleId></ArticleIdList></Reference><Reference><Citation>Kioumourtzoglou M.-A., Rotem R.S., Seals R.M., Gredal O., Hansen J., Weisskopf M.G. Diabetes mellitus, obesity, and diagnosis of amyotrophic lateral sclerosis: A population-based study. JAMA Neurol. 2015;72:905&#x2013;911. doi: 10.1001/jamaneurol.2015.0910.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2015.0910</ArticleId><ArticleId IdType="pmc">PMC4975611</ArticleId><ArticleId IdType="pubmed">26030836</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller R.G., Mitchell J.D., Moore D.H. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND) Cochrane Database Syst. Rev. 2012 doi: 10.1002/14651858.CD001447.pub3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD001447.pub3</ArticleId><ArticleId IdType="pmc">PMC7055506</ArticleId><ArticleId IdType="pubmed">22419278</ArticleId></ArticleIdList></Reference><Reference><Citation>Crockford C., Newton J., Lonergan K., Chiwera T., Booth T., Chandran S., Colville S., Heverin M., Mays I., Pal S., et al. ALS-specific cognitive and behavior changes associated with advancing disease stage in ALS. Neurology. 2018;91:e1370&#x2013;e1380. doi: 10.1212/WNL.0000000000006317.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000006317</ArticleId><ArticleId IdType="pmc">PMC6177274</ArticleId><ArticleId IdType="pubmed">30209236</ArticleId></ArticleIdList></Reference><Reference><Citation>Phukan J., Pender N.P., Hardiman O. Cognitive impairment in amyotrophic lateral sclerosis. Lancet Neurol. 2007;6:994&#x2013;1003. doi: 10.1016/S1474-4422(07)70265-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(07)70265-X</ArticleId><ArticleId IdType="pubmed">17945153</ArticleId></ArticleIdList></Reference><Reference><Citation>van Es M.A., Hardiman O., Chio A., Al-Chalabi A., Pasterkamp R.J., Veldink J.H., van den Berg L.H. Amyotrophic lateral sclerosis. Lancet. 2017;390:2084&#x2013;2098. doi: 10.1016/S0140-6736(17)31287-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(17)31287-4</ArticleId><ArticleId IdType="pubmed">28552366</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Rheenen W., Shatunov A., Dekker A.M., McLaughlin R.L., Diekstra F.P., Pulit S.L., Van Der Spek R.A., V&#xf5;sa U., De Jong S., Robinson M.R., et al. Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis. Nat. Genet. 2016;48:1043&#x2013;1048. doi: 10.1038/ng.3622.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.3622</ArticleId><ArticleId IdType="pmc">PMC5556360</ArticleId><ArticleId IdType="pubmed">27455348</ArticleId></ArticleIdList></Reference><Reference><Citation>Fogh I., Ratti A., Gellera C., Lin K., Tiloca C., Moskvina V., Corrado L., Sorar&#xf9; G., Cereda C., Corti S., et al. A genome-wide association meta-analysis identifies a novel locus at 17q11. 2 associated with sporadic amyotrophic lateral sclerosis. Hum. Mol. Genet. 2013;23:2220&#x2013;2231. doi: 10.1093/hmg/ddt587.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddt587</ArticleId><ArticleId IdType="pmc">PMC3959809</ArticleId><ArticleId IdType="pubmed">24256812</ArticleId></ArticleIdList></Reference><Reference><Citation>Fogh I., Lin K., Tiloca C., Rooney J., Gellera C., Diekstra F.P., Ratti A., Shatunov A., Van Es M.A., Proitsi P., et al. Association of a locus in the CAMTA1 gene with survival in patients with sporadic amyotrophic lateral sclerosis. JAMA Neurol. 2016;73:812&#x2013;820. doi: 10.1001/jamaneurol.2016.1114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2016.1114</ArticleId><ArticleId IdType="pmc">PMC5556366</ArticleId><ArticleId IdType="pubmed">27244217</ArticleId></ArticleIdList></Reference><Reference><Citation>Iacoangeli A., Al Khleifat A., Jones A.R., Sproviero W., Shatunov A., Opie-Martin S., Morrison K.E., Shaw P.J., Shaw C.E., Fogh I., et al. C9orf72 intermediate expansions of 24&#x2013;30 repeats are associated with ALS. Acta Neuropathol. Commun. 2019;7:115. doi: 10.1186/s40478-019-0724-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-019-0724-4</ArticleId><ArticleId IdType="pmc">PMC6637621</ArticleId><ArticleId IdType="pubmed">31315673</ArticleId></ArticleIdList></Reference><Reference><Citation>Project MinE ALS Sequencing Consortium Project MinE: Study design and pilot analyses of a large-scale whole-genome sequencing study in amyotrophic lateral sclerosis. Eur. J. Hum. Genet. 2018;26:1537&#x2013;1546. doi: 10.1038/s41431-018-0177-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41431-018-0177-4</ArticleId><ArticleId IdType="pmc">PMC6138692</ArticleId><ArticleId IdType="pubmed">29955173</ArticleId></ArticleIdList></Reference><Reference><Citation>Kenna K.P., Van Doormaal P.T., Dekker A.M., Ticozzi N., Kenna B.J., Diekstra F.P., Van Rheenen W., Van Eijk K.R., Jones A.R., Keagle P., et al. NEK1 variants confer susceptibility to amyotrophic lateral sclerosis. Nat. Genet. 2016;48:1037&#x2013;1042. doi: 10.1038/ng.3626.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.3626</ArticleId><ArticleId IdType="pmc">PMC5560030</ArticleId><ArticleId IdType="pubmed">27455347</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Rheenen W., Diekstra F.P., Harschnitz O., Westeneng H.-J., van Eijk K.R., Saris C.G., Groen E.J., Van Es M.A., Blauw H.M., Van Vught P.W. Whole blood transcriptome analysis in amyotrophic lateral sclerosis: A biomarker study. PLoS ONE. 2018;13:e0198874. doi: 10.1371/journal.pone.0198874.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0198874</ArticleId><ArticleId IdType="pmc">PMC6016933</ArticleId><ArticleId IdType="pubmed">29939990</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Spek R.A., Van Rheenen W., Pulit S.L., Kenna K.P., van den Berg L.H., Veldink J.H., On behalf of the Project MinE ALS Sequencing Consortium The Project MinE databrowser: Bringing large-scale whole-genome sequencing in ALS to researchers and the public. Amyotroph. Lateral Scler. Front. Degener. 2019;20:432&#x2013;440. doi: 10.1080/21678421.2019.1606244.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2019.1606244</ArticleId><ArticleId IdType="pubmed">31280677</ArticleId></ArticleIdList></Reference><Reference><Citation>Farhan S.M., Howrigan D.P., Abbott L.E., Klim J.R., Topp S.D., Byrnes A.E., Churchhouse C., Phatnani H., Smith B.N., Rampersaud E., et al. Exome sequencing in amyotrophic lateral sclerosis implicates a novel gene, DNAJC7, encoding a heat-shock protein. Nat. Neurosci. 2019;22:1966&#x2013;1974. doi: 10.1038/s41593-019-0530-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-019-0530-0</ArticleId><ArticleId IdType="pmc">PMC6919277</ArticleId><ArticleId IdType="pubmed">31768050</ArticleId></ArticleIdList></Reference><Reference><Citation>Al Khleifat A., Iacoangeli A., Shatunov A., Fang T., Sproviero W., Jones A.R., Opie-Martin S., Morrison K.E., Shaw P.J., Shaw C.E., et al. Telomere length is greater in ALS than in controls: A whole genome sequencing study. Amyotroph. Lateral Scler. Front. Degener. 2019;20:229&#x2013;234. doi: 10.1080/21678421.2019.1586951.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2019.1586951</ArticleId><ArticleId IdType="pmc">PMC6567548</ArticleId><ArticleId IdType="pubmed">30931641</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>